Am J Epidemiol 2002; 156:127-131.
Copyright © 2002 by the
Johns Hopkins Bloomberg School of Public Health
ORIGINAL CONTRIBUTIONS |
Baseline Cataract Type and 10-Year Mortality in the Italian-American Case-Control Study of Age-related Cataract
1 Ophthalmology, Department of Science, ORL-Odonto-Oftalmologiche, University of Parma, Parma, Italy.
2 Laboratory for Epidemiology and Biostatistics, Istituto Superiore di Sanità, Roma, Italy.
Age-related cataract is reported to be associated with increased risk of death. The authors investigated the association of presence and type of cataract with mortality in the participants of the Italian-American Case-Control Cataract Study (Parma, Italy, 1987–1989), which included 1,008 persons aged 45–79 years who had age-related cataract and 469 who had clear lenses. Slit-lamp and retroillumination lens photographs were taken at baseline and graded with the Lens Opacities Classification System II. During 10 years of follow-up (range, 8.9–11.8 years; 11,318 person-years), the authors collected information on 1,429 participants and documented 339 deaths. After adjustment for age, sex, and other mortality risk factors, mixed cataracts with a nuclear/posterior subcapsular component were significantly associated with higher risk of death by Cox proportional hazards regression analyses. Hazard ratios were 2.26 (95% confidence interval (CI): 1.07, 4.76) for nuclear/posterior subcapsular and 1.62 (95% CI: 1.01, 2.61) for cortical/nuclear/posterior subcapsular opacities. In multivariate analysis, mixed types of opacity (any) were associated with increased mortality for malignancy (hazard ratio = 1.81, 95% CI: 1.04, 3.15) and "other" causes (hazard ratio = 2.29, 95% CI: 1.07, 4.92). These findings are compatible with the hypothesis that mixed types of cataract with a nuclear/posterior subcapsular component are indicators of accelerated aging. Am J Epidemiol 2002;156:127–31.
aging; cataract; mortality
Abbreviations: Abbreviations: CI, confidence interval; HR, hazard ratio.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. Cugati, R. G. Cumming, W. Smith, G. Burlutsky, P. Mitchell, and J. J. Wang Visual Impairment, Age-Related Macular Degeneration, Cataract, and Long-term Mortality: The Blue Mountains Eye Study Arch Ophthalmol, July 1, 2007; 125(7): 917 - 924. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. S. Zubenko, W. N. Zubenko, B. S. Maher, and N. S. Wolf Reduced Age-Related Cataracts Among Elderly Persons Who Reach Age 90 With Preserved Cognition: A Biomarker of Successful Aging? J. Gerontol. A Biol. Sci. Med. Sci., May 1, 2007; 62(5): 500 - 506. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. D. Knudtson, B. E. K. Klein, and R. Klein Age-related eye disease, visual impairment, and survival: the beaver dam eye study. Arch Ophthalmol, February 1, 2006; 124(2): 243 - 249. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Thiagarajan, J. R. Evans, L. Smeeth, R. P. L. Wormald, and A. E. Fletcher Cause-Specific Visual Impairment and Mortality: Results From a Population-Based Study of Older People in the United Kingdom Arch Ophthalmol, October 1, 2005; 123(10): 1397 - 1403. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
AREDS Research Group Associations of Mortality With Ocular Disorders and an Intervention of High-Dose Antioxidants and Zinc in the Age-Related Eye Disease Study: AREDS Report No. 13 Arch Ophthalmol, May 1, 2004; 122(5): 716 - 726. [Abstract] [Full Text] [PDF]
|
|